Also trades as: BIOC (NASDAQ) · $vol 1M
BIOCQ OTC
Biocept, Inc.
1W: -0.0%
1M: +100.0%
3M: -0.0%
YTD: +100.0%
1Y: +100.0%
3Y: -100.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$26M
-57.8% ▼
3Y CAGR: +67.2%
Gross Profit
-$3M
-111.0% ▼
Operating Income
-$32M
-1227.6% ▼
Net Income
-$32M
-1036.2% ▼
EPS (Diluted)
$-56.78
-890.9% ▼
EBITDA
-$30M
-3340.4% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|
| Revenue | $6M | $27M | $61M | $26M |
| YoY Growth | +0.0% | +396.7% | +123.0% | -57.8% |
| Cost of Revenue | $11M | $21M | $38M | $28M |
| Gross Profit | -$5M | $6M | $23M | -$3M |
| Gross Margin | -98.6% | 22.3% | 38.3% | -10.0% |
| R&D Expenses | $5M | $5M | $5M | $6M |
| SG&A Expenses | $13M | $16M | $21M | $23M |
| Operating Expenses | $18M | $22M | $26M | $29M |
| Operating Income | -$23M | -$15M | -$2M | -$32M |
| Operating Margin | -417.1% | -56.3% | -3.9% | -123.7% |
| Interest Expense | $250K | $236K | $290K | $316K |
| Income Before Tax | -$25M | -$18M | -$3M | -$32M |
| Tax Expense | $0 | $0 | $125K | -$125K |
| Net Income | -$25M | -$18M | -$3M | -$32M |
| Net Margin | -454.7% | -64.8% | -4.6% | -124.1% |
| EPS (Diluted) | $-365.01 | $-45.10 | $-5.73 | $-56.78 |
| EBITDA | -$24M | -$17M | -$879K | -$30M |
| Shares Outstanding | 68869 | 394841 | 492526 | 565127 |